Skip to content

MK-677 (ibutamoren)

Peptidesnon-peptide secretagogueEarly stage

Availability Not yet prescribable · sold for research use only

What it is

MK-677, also called ibutamoren, is not a peptide. It is an orally active small molecule that mimics ghrelin at the same receptor the growth hormone peptides target, developed by Merck and never brought to market. It is sold alongside peptides on clinic menus, which is worth naming plainly, because the chemistry, the route, and the regulatory footing are all different.

Why people take it

It is the pill on an injectable menu. People choose it to raise growth hormone and IGF-1 without needles, usually for lean mass, sleep, and appetite, and the appetite effect is strong enough that some buy it specifically to eat more during a gaining phase.

How it's delivered

Oral, once daily, and continuously rather than in courses. Because the compound raises fasting glucose, a monitored program tracks glucose and HbA1c rather than only body composition.

Where the evidence stands

MK-677 has the best human data of anything on the growth hormone menu, and that data is a cautionary tale. A randomized two-year study in healthy older adults found MK-677 raised growth hormone and IGF-1 and added weight, about 2.7 kg against 0.8 kg on placebo, with the gain split across fat-free mass and fat. It did not improve strength or function. Fasting glucose rose, HbA1c rose, insulin sensitivity fell, and cortisol rose. FDA keeps ibutamoren in the category reserved for substances raising significant safety risks, its advisory committee voted against compounding use in October 2024, and WADA prohibits it.

Estimated cost

  • No approved or lawfully compounded product, so no reference price
  • Glucose and HbA1c monitoring on top
  • Not covered by insurance

Who offers it

We don't list providers for MK-677: there is no approved product and no lawful compounding route, so there is nothing we can point you to. Anything sold online is unregulated.

Go deeper

The compound page, MK-677 in the Peptide Explorer, is the depth layer and covers why a non-peptide sits in a peptide catalog. The lane guide, Peptides for Growth Hormone Support, covers the axis and what the trial evidence actually showed.

Longevity.io is for educational purposes only and is not medical advice. Weight gained without strength gained, alongside worse glucose control, is a trade worth discussing with a clinician who knows the whole picture. Confirm eligibility, product source, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint